Skip to main content
Fadi Asfour

Fadi Asfour, MD, MBBS

Languages spoken: English, Arabic

Clinical Locations

Eccles Primary Children's Outpatient Services Building

Salt Lake City
  • Dr. Asfour received his Bachelor of Medicine, Bachelor of Surgery degree from Jordan University of Science and Technology. Dr. Asfour completed his pediatric residency at The Women and Children´s Hospital of Buffalo, and his pediatric Pulmonary Fellowship at Children’s Hospital of Los Angeles. Dr. Asfour is board-certified in pediatrics and pediatric pulmonology. Dr. Asfour is currently an Associate Professor of Pediatric Pulmonology at the University of Utah and is in the Division of Pulmonary and Sleep Medicine at Primary Children´s Hospital. Dr. Asfour’s interests include cystic fibrosis, quality improvement, aerodigestive disorders, asthma and general pulmonology.

    Board Certification

    American Board of Pediatrics (Sub: Pediatric Pulmonology)
    National Board of Medical Examiners
  • Dr. Asfour received his Bachelor of Medicine, Bachelor of Surgery degree from Jordan University of Science and Technology. Dr. Asfour completed his pediatric residency at The Women and Children´s Hospital of Buffalo, and his pediatric Pulmonary Fellowship at Children’s Hospital of Los Angeles. Dr. Asfour is board-certified in pediatrics and pediatric pulmonology. Dr. Asfour is currently an Associate Professor of Pediatric Pulmonology at the University of Utah and is in the Division of Pulmonary and Sleep Medicine at Primary Children´s Hospital. Dr. Asfour’s interests include cystic fibrosis, quality improvement, aerodigestive disorders, asthma and general pulmonology.

    Board Certification and Academic Information

    Academic Departments Pediatrics -Primary
    Board Certification
    American Board of Pediatrics (Sub: Pediatric Pulmonology)
    National Board of Medical Examiners

    Education history

    Fellowship Pulmonary - University of Southern California at Children’s Hospital Los Angeles Fellow
    Pediatric - University of Buffalo at The Women and Children’s Hospital of Buffalo M.D.
    Internship Internal Medicine/Preliminary - North Side Hospital, Affiliated with North Eastern Ohio Universities Colleges of Medicine Intern
    Al-Basheer Hospital Intern
    Professional Medical Medicine - Jordan University of Science and Technology/King Abdullah University Hospital M.B.B.S.

    Selected Publications

    Journal Article

    1. Blaseg NA, Robson JO, Patel RA, Asfour F, Pohl JF (2024). Gastrointestinal Pathologies in Pediatric Patients With Cystic Fibrosis Undergoing Endoscopy: A Single-Center Retrospective Review Over 15 Years. Cureus, 16(4), e59018. (Read full article)
    2. Reed JE, Johnson JK, Zanni R, Messier R, Asfour F, Godfrey MM (2024). Quality of locally designed surveys in a quality improvement collaborative: review of survey validity and identification of common errors. BMJ Open Qual, 13(1). (Read full article)
    3. Liou TG, Argel N, Asfour F, Brown PS, Chatfield BA, Cox DR, Daines CL, Durham D, Francis JA, Glover B, Helms M, Heynekamp T, Hoidal JR, Jensen JL, Kartsonaki C, Keogh R, Kopecky CM, Lechtzin N, Li Y, Lysinger J, Molina O, Nakamura C, Packer KA, Paine R 3rd, Poch KR, Quittner AL, Radford P, Redway AJ, Sagel SD, Szczesniak RD, Sprandel S, Taylor-Cousar JL, Vroom JB, Yoshikawa R, Clancy JP, Elborn JS, Olivier KN, Adler FR (2024). Airway inflammation accelerates pulmonary exacerbations in cystic fibrosis. iScience, 27(3), 108835. (Read full article)
    4. Yuzyuk T, McDonald CM, Zuromski LM, De Biase I, Johnson L, Williams N, Meihls S, Asfour F (2023). Improvement of lipid and lipoprotein profiles in children and adolescents with cystic fibrosis on CFTR modulator therapy. J Cyst Fibros. (Read full article)
    5. Jeffery T Zobell PharmD, BCPPS, Justin Moss CPhT, Jenna Creelman PharmD, Rilee Christensen PharmD candidate, Bevan Jensen PharmD, MBA, Jennifer Stewart APRN, Kristen Ameel MD, Fadi Asfour MD (2023). Implementation of a comprehensive pharmacy-driven immunization care process model in a pediatric cystic fibrosis clinic. Pediatr Pulmonol, 58(4), 1145-1151.
    6. Zobell JT, Moss J, Creelman J, Christensen R, Jensen B, Stewart J, Ameel K, Asfour F (2023). Implementation of a comprehensive pharmacy-driven immunization care process model in a pediatric cystic fibrosis clinic. Pediatr Pulmonol. (Read full article)
    7. Rayment JH, Asfour F, Rosenfeld M, Higgins M, Liu L, Mascia M, Paz-Diaz H, Tian S, Zahigian R, McColley SA, VX16-809-122 Study Group (2022). A Phase 3, Open-Label Study of Lumacaftor/Ivacaftor in Children 1 to Less Than 2 Years of Age With Cystic Fibrosis Homozygous for F508del-CFTR. Am J Respir Crit Care Med. (Read full article)
    8. Huang L, Lai HJ, Antos N, Rock MJ, Asfour F, Howenstine M, Gaffin JM, Farrell PM (2022). Defining and identifying early-onset lung disease in cystic fibrosis with cumulative clinical characteristics. Pediatr Pulmonol. (Read full article)
    9. Albon D, Thomas L, Hoberg L, Stamper S, Somerville L, Varghese P, Balasa E, Roman M, Britto MT, Miner M, Gehring E, Gammon C, Amin RS, Seid M, Powers M, CF Learning Network telehealth iLab working group (2022). Cystic fibrosis learning network telehealth innovation lab during the COVID-19 pandemic: a success QI story for interdisciplinary care and agenda setting. BMJ Open Qual, 11(2). (Read full article)
    10. David P Nichols, Pradeep K Singh, Arthur Baines, Lindsay J Caverly, James F Chmiel, Ronald L GIbson, Jorge Lascano, Sarah J Morgan, George Retsch- Bogart, Lisa Saiman, Hossein Sadeghi, Joanne L Billings, Sonya L Heltshe, Shannon Kirby, Ada Kong, Jerry A Nick, Nicole Mayer- Hamblett, TEACH Study Group (2021). Testing the effects of combining azithromycin with inhaled tobramycin for P. aeruginosa in cystic fibrosis: a randomised, controlled clinical trial. Thorax.

    Abstract

    1. Yuzyuk, T Balogun, K Meihls, S Williams, N McDonald, KM Asfour, F (2020). Dyslipidemia in Children and Adolescents with Cystic Fibrosis [Abstract]. 55(S2).